Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-06-27
1992-03-24
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 544298, 544326, 544329, A61K 31505, A61K 31445, C07D40114
Patent
active
050989049
ABSTRACT:
A series of pyprimidinyl compounds of formulae I, II and III; ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from hydrogen and hydroxy;
REFERENCES:
patent: 3398151 (1968-08-01), Wu et al.
patent: 3558777 (1971-01-01), Wu et al.
patent: 3717634 (1973-02-01), Wu et al.
patent: 3907801 (1975-09-01), Wu et al.
patent: 3976776 (1976-08-01), Wu et al.
patent: 4361565 (1982-11-01), Temple, Jr. et al.
patent: 4411901 (1983-10-01), Temple, Jr. et al.
patent: 4423049 (1983-12-01), Temple, Jr.
patent: 4524206 (1985-06-01), New et al.
patent: 4668687 (1987-05-01), Yevich et al.
patent: 4826843 (1989-05-01), Mattson et al.
Butler et al., "Amnesia-Reversal Activity, etc."J. Med. Chem., 1984, 27, 684-691.
Malawska, et al., "Synthesis and Pharmacological, etc." Pol. J. Pharmacol. Pharm., 1982, 34, 373-382.
Brady Michael E.
Mattson Ronald J.
Mayol Robert
Bristol--Myers Squibb Company
Han William T.
Morris Patricia L.
LandOfFree
Cerebral function enhancing pyrimidinyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cerebral function enhancing pyrimidinyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cerebral function enhancing pyrimidinyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010396